Richard Tothill
Richard Tothill
Peter MacCallum Cancer Centre
Verified email at petermac.org
Title
Cited by
Cited by
Year
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome
RW Tothill, AV Tinker, J George, R Brown, SB Fox, S Lade, DS Johnson, ...
Clinical cancer research 14 (16), 5198-5208, 2008
11772008
Whole–genome characterization of chemoresistant ovarian cancer
AM Patch, EL Christie, D Etemadmoghadam, DW Garsed, J George, ...
Nature 521 (7553), 489-494, 2015
9012015
Next-generation sequencing for cancer diagnostics: a practical perspective
C Meldrum, MA Doyle, RW Tothill
The Clinical Biochemist Reviews 32 (4), 177, 2011
4602011
Options available—from start to finish—for obtaining data from DNA microarrays II
AJ Holloway, RK Van Laar, RW Tothill, DDL Bowtell
nature genetics 32 (4), 481-489, 2002
3672002
CONTRA: copy number analysis for targeted resequencing
J Li, R Lupat, KC Amarasinghe, ER Thompson, MA Doyle, GL Ryland, ...
Bioinformatics 28 (10), 1307-1313, 2012
2712012
Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas
D Etemadmoghadam, A Defazio, R Beroukhim, C Mermel, J George, ...
Clinical cancer research 15 (4), 1417-1427, 2009
2402009
An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin
RW Tothill, A Kowalczyk, D Rischin, A Bousioutas, I Haviv, RK Van Laar, ...
Cancer Research 65 (10), 4031-4040, 2005
2232005
Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis
S Moran, A MartÝnez-Card˙s, S Sayols, E MusulÚn, C Bala˝ß, ...
The Lancet Oncology 17 (10), 1386-1395, 2016
2092016
Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles
ER Thompson, MA Doyle, GL Ryland, SM Rowley, DYH Choong, ...
PLoS Genet 8 (9), e1002894, 2012
1922012
UV-associated mutations underlie the etiology of MCV-negative Merkel cell carcinomas
SQ Wong, K Waldeck, IA Vergara, J Schr÷der, J Madore, JS Wilmott, ...
Cancer research 75 (24), 5228-5234, 2015
1792015
Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells
L Pirola, A Balcerczyk, RW Tothill, I Haviv, A Kaspi, S Lunke, M Ziemann, ...
Genome research 21 (10), 1601-1615, 2011
1772011
Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors
MS Anglesio, JM Arnold, J George, AV Tinker, R Tothill, N Waddell, ...
Molecular cancer research 6 (11), 1678-1690, 2008
1162008
BRAF/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damage
VJ Mar, SQ Wong, J Li, RA Scolyer, C McLean, AT Papenfuss, RW Tothill, ...
Clinical Cancer Research 19 (17), 4589-4598, 2013
1152013
68 Ga-DOTATATE and 18 F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity
CA Chang, DA Pattison, RW Tothill, G Kong, TJ Akhurst, RJ Hicks, ...
Cancer Imaging 16 (1), 1-12, 2016
842016
Massively‐parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary
RW Tothill, J Li, L Mileshkin, K Doig, T Siganakis, P Cowin, A Fellowes, ...
The Journal of pathology 231 (4), 413-423, 2013
822013
Socrates: identification of genomic rearrangements in tumour genomes by re-aligning soft clipped reads
J Schr÷der, A Hsu, SE Boyle, G Macintyre, M Cmero, RW Tothill, ...
Bioinformatics 30 (8), 1064-1072, 2014
762014
An evolutionarily conserved function of polycomb silences the MHC Class I antigen presentation pathway and enables immune evasion in cancer
ML Burr, CE Sparbier, KL Chan, YC Chan, A Kersbergen, EYN Lam, ...
Cancer Cell 36 (4), 385-401. e8, 2019
722019
Loss of heterozygosity: what is it good for?
GL Ryland, MA Doyle, D Goode, SE Boyle, DYH Choong, SM Rowley, J Li, ...
BMC medical genomics 8 (1), 45, 2015
712015
The genomic landscape of phaeochromocytoma
A Flynn, D Benn, R Clifton‐Bligh, B Robinson, AH Trainer, P James, ...
The Journal of pathology 236 (1), 78-89, 2015
612015
A signature predicting poor prognosis in gastric and ovarian cancer represents a coordinated macrophage and stromal response
RA Busuttil, J George, RW Tothill, K Ioculano, A Kowalczyk, C Mitchell, ...
Clinical cancer research 20 (10), 2761-2772, 2014
582014
The system can't perform the operation now. Try again later.
Articles 1–20